Rapamycin Reversed Autism-Like Symptoms in Mice in Hours
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- UCLA Health researchers found that mild inflammation during pregnancy caused mouse offspring to develop persistent brain overactivity, sensory sensitivity, repetitive behaviors, and increased seizure risk lasting into adulthood.
- A single dose of rapamycin improved brain communication and behavior across nearly every measurement in the affected adult mice within about two hours.
- Scientists concluded the response was too fast for structural brain repair, meaning rapamycin normalized brain circuit function rather than rebuilding physical differences formed during early development.
- Rapamycin reduced excessive mTOR pathway signaling and reversed abnormal gene expression patterns tied to autism, epilepsy, and ion channel function, with the strongest effects in excitatory neurons.
- The drug's benefits were temporary, and daily treatment became less effective after several weeks as the mice developed tolerance.
- Dr. Harley Kornblum and colleagues warned rapamycin should not be considered a treatment for people due to its toxicity, temporary effects, and the animal-only nature of the research.
- The study, published in Nature Communications, points researchers toward targets like sensory circuit neuromodulation and excitation-inhibition balance rather than rapamycin itself as a therapy.
Why it matters: The study reframes autism research by showing adult brain circuits can be functionally normalized even when structural differences from early development persist — redirecting the field toward circuit-level interventions like sensory neuromodulation, rather than attempts to reverse the underlying physical brain changes.
